Prevalence of smoking during COVID19 (n = 1844). by Mahmoud A. Alomari (14780446)

“…</p><p>Conclusions</p><p>Changes in the SH during COVID-19 have been reported in about 50% of participants who smoke tobacco, with a more reported decrease than increase in use. …”

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

HPD 1466 decreases empty capsid accumulation in cells replicating HBV. by Daniel P. Bradley (10306893)

Subjects:

Cellular co-infection decreases the potential for superinfection. by Brigitte E. Martin (8366847)

Supplementary Material for: Cardiac Troponin Is Elevated in Patients with Thyrotoxicosis and Decreases as Thyroid Function Improves and Brain Natriuretic Peptide Levels Decrease by Watanabe N. (4118812)

“…A decrease in FT₄ in the first 3 months was weakly correlated with decreases in hsTnI (ρ = 0.32, <i>p</i> = 0.0004) and BNP (ρ = 0.32; <i>p</i> = 0.0003). …”

The participant demographic (n = 1844). by Mahmoud A. Alomari (14780446)

“…</p><p>Conclusions</p><p>Changes in the SH during COVID-19 have been reported in about 50% of participants who smoke tobacco, with a more reported decrease than increase in use. …”

RAC1 inhibition results in a decrease in oxidative phosphorylation. by Shruthi Sriramkumar (12705564)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

Subjects:

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

“…The white box indicates the location of the magnified figure. Scale bar: 50 μm. (<b>bottom, right</b>) Quantitative analysis of autophagic activity <i>in vivo</i>. …”

Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

“…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”

Quantitative decrease of apolipoprotein-A1 by cohort. by Thierry Poynard (38084)

NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

Decrease of autoantibody levels in highly inflammatory NSG mice. by Henrika Jodeleit (4722312)

LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

LOH resulting in 189R/R produces a strong decrease in drug susceptibility. by Pétra Vande Zande (17628246)

Decrease of apolipoprotein-A1 by gender and age in US cohort. by Thierry Poynard (38084)

Comparison of 6 virtues between the two groups [PCOS (n = 49); non-PCOS (n = 50)]. by Ghina Ghazeeri (766076)

NatB-inactivation decreased Drk levels through its N-terminal sequences, which was regulated by the N-end rule E3 ubiquitin ligase POE/UBR4. by Zhentao Sheng (107495)